Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cold Tumors: A Therapeutic Challenge for Immunotherapy.
Bonaventura P, Shekarian T, Alcazer V, Valladeau-Guilemond J, Valsesia-Wittmann S, Amigorena S, Caux C, Depil S. Bonaventura P, et al. Front Immunol. 2019 Feb 8;10:168. doi: 10.3389/fimmu.2019.00168. eCollection 2019. Front Immunol. 2019. PMID: 30800125 Free PMC article. Review.
IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer.
Hubert M, Gobbini E, Couillault C, Manh TV, Doffin AC, Berthet J, Rodriguez C, Ollion V, Kielbassa J, Sajous C, Treilleux I, Tredan O, Dubois B, Dalod M, Bendriss-Vermare N, Caux C, Valladeau-Guilemond J. Hubert M, et al. Sci Immunol. 2020 Apr 17;5(46):eaav3942. doi: 10.1126/sciimmunol.aav3942. Epub 2020 Apr 17. Sci Immunol. 2020. PMID: 32303573
Hepatitis B virus exploits C-type lectin receptors to hijack cDC1s, cDC2s and pDCs.
Ouaguia L, Dufeu-Duchesne T, Leroy V, Decaens T, Reiser JB, Sosa Cuevas E, Durantel D, Valladeau-Guilemond J, Bendriss-Vermare N, Chaperot L, Aspord C. Ouaguia L, et al. Among authors: valladeau guilemond j. Clin Transl Immunology. 2020 Dec 8;9(12):e1208. doi: 10.1002/cti2.1208. eCollection 2020. Clin Transl Immunology. 2020. PMID: 33312564 Free PMC article.
Type 1 conventional dendritic cells and interferons are required for spontaneous CD4+ and CD8+ T-cell protective responses to breast cancer.
Mattiuz R, Brousse C, Ambrosini M, Cancel JC, Bessou G, Mussard J, Sanlaville A, Caux C, Bendriss-Vermare N, Valladeau-Guilemond J, Dalod M, Crozat K. Mattiuz R, et al. Among authors: valladeau guilemond j. Clin Transl Immunology. 2021 Jul 14;10(7):e1305. doi: 10.1002/cti2.1305. eCollection 2021. Clin Transl Immunology. 2021. PMID: 34277006 Free PMC article.
Diversification of circulating and tumor-infiltrating plasmacytoid DCs towards the P3 (CD80+ PDL1-)-pDC subset negatively correlated with clinical outcomes in melanoma patients.
Sosa Cuevas E, Bendriss-Vermare N, Mouret S, De Fraipont F, Charles J, Valladeau-Guilemond J, Chaperot L, Aspord C. Sosa Cuevas E, et al. Among authors: valladeau guilemond j. Clin Transl Immunology. 2022 May 3;11(5):e1382. doi: 10.1002/cti2.1382. eCollection 2022. Clin Transl Immunology. 2022. PMID: 35517992 Free PMC article.
22 results